These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21516058)

  • 1. Association between pharmacodynamic biomarkers and clinical events in the early phase after kidney transplantation: a single-center pilot study.
    Wieland E; Shipkova M; Martius Y; Hasche G; Klett C; Bolley R; Olbricht CJ
    Ther Drug Monit; 2011 Jun; 33(3):341-9. PubMed ID: 21516058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target enzyme activity as a biomarker for immunosuppression.
    Glander P; Budde K
    Ther Drug Monit; 2010 Jun; 32(3):257-60. PubMed ID: 20431505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 4. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
    Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
    Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
    Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of T-cell proliferation for individualizing immunosuppressive therapy for transplantation patients.
    Ohdan H
    Clin Pharmacol Ther; 2010 Jan; 87(1):23-6. PubMed ID: 20019698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of antibody-mediated rejection after kidney transplantation.
    Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
    Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers as a tool for management of immunosuppression in transplant patients.
    Wieland E; Olbricht CJ; Süsal C; Gurragchaa P; Böhler T; Israeli M; Sommerer C; Budde K; Hartmann B; Shipkova M; Oellerich M
    Ther Drug Monit; 2010 Oct; 32(5):560-72. PubMed ID: 20814352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
    Gotti E; Perico N; Gaspari F; Cattaneo D; Lesti MD; Ruggenenti P; Segoloni G; Salvadori M; Rigotti P; Valente U; Donati D; Sandrini S; Federico S; Sparacino V; Mourad G; Bosmans JL; Dimitrov BD; Iordache BE; Remuzzi G
    Transplant Proc; 2005 Jun; 37(5):2037-40. PubMed ID: 15964332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation.
    Zhang Y; Guan DL; Xia CQ; Han ZY; Xu JJ; Gao JZ; Wu KR
    Transplant Proc; 2005 Dec; 37(10):4208-10. PubMed ID: 16387079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
    Böhler T; Nolting J; Kamar N; Gurragchaa P; Reisener K; Glander P; Neumayer HH; Budde K; Klupp J
    Ther Drug Monit; 2007 Feb; 29(1):77-86. PubMed ID: 17304154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients.
    Millán O; Urtasun N; Brunet M
    Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
    Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
    Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
    Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
    Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation.
    Raggi MC; Siebert SB; Steimer W; Schuster T; Stangl MJ; Abendroth DK
    Transplantation; 2010 Dec; 90(12):1536-41. PubMed ID: 21076373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.